Repetitive mild traumatic brain injury affects inflammation and excitotoxic mRNA expression at acute and chronic time-points

PLoS One. 2021 May 7;16(5):e0251315. doi: 10.1371/journal.pone.0251315. eCollection 2021.

Abstract

The cumulative effect of mild traumatic brain injuries (mTBI) can result in chronic neurological damage, however the molecular mechanisms underpinning this detriment require further investigation. A closed head weight drop model that replicates the biomechanics and head acceleration forces of human mTBI was used to provide an exploration of the acute and chronic outcomes following single and repeated impacts. Adult male C57BL/6J mice were randomly assigned into one of four impact groups (control; one, five and 15 impacts) which were delivered over 23 days. Outcomes were assessed 48 hours and 3 months following the final mTBI. Hippocampal spatial learning and memory assessment revealed impaired performance in the 15-impact group compared with control in the acute phase that persisted at chronic measurement. mRNA analyses were performed on brain tissue samples of the cortex and hippocampus using quantitative RT-PCR. Eight genes were assessed, namely MAPT, GFAP, AIF1, GRIA1, CCL11, TARDBP, TNF, and NEFL, with expression changes observed based on location and follow-up duration. The cortex and hippocampus showed vulnerability to insult, displaying upregulation of key excitotoxicity and inflammation genes. Serum samples showed no difference between groups for proteins phosphorylated tau and GFAP. These data suggest that the cumulative effect of the impacts was sufficient to induce mTBI pathophysiology and clinical features. The genes investigated in this study provide opportunity for further investigation of mTBI-related neuropathology and may provide targets in the development of therapies that help mitigate the effects of mTBI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain / pathology
  • Brain Concussion / genetics*
  • Brain Concussion / metabolism
  • Brain Concussion / pathology
  • Calcium-Binding Proteins / genetics
  • Calcium-Binding Proteins / metabolism
  • Chemokine CCL11 / genetics
  • Chemokine CCL11 / metabolism
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Disease Models, Animal
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / metabolism
  • Inflammation / genetics*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Mice
  • Microfilament Proteins / genetics
  • Microfilament Proteins / metabolism
  • Neurofilament Proteins / genetics
  • Neurofilament Proteins / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, AMPA / genetics
  • Receptors, AMPA / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • tau Proteins / genetics
  • tau Proteins / metabolism

Substances

  • Aif1 protein, mouse
  • Calcium-Binding Proteins
  • Chemokine CCL11
  • DNA-Binding Proteins
  • Glial Fibrillary Acidic Protein
  • Mapt protein, mouse
  • Microfilament Proteins
  • Neurofilament Proteins
  • RNA, Messenger
  • Receptors, AMPA
  • Tumor Necrosis Factor-alpha
  • glial fibrillary astrocytic protein, mouse
  • neurofilament protein L
  • tau Proteins
  • glutamate receptor ionotropic, AMPA 1

Grants and funding

This project was supported by the Australian Government Research Training Scheme. Funding to publish this study was provided by the Mackay Hospital and Health Service and the Mackay Institute of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.